<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Clinical Impact of &amp;quot;Post Approval Pregnancy Safety Studies&amp;quot;</title>
  <description>In this episode, we welcome rheumatologist Dr. Lisa R. Sammaritano to discuss the FDA guidance, Postapproval Pregnancy Safety Studies. We explore what current evidence tells us about medication safety during pregnancy, the challenges of distinguishing drug effects from disease-related risks, and how to interpret findings from small pregnancy registries. We also discuss underreported pregnancy outcomes, the role of rheumatologists in strengthening the evidence base, and the key unanswered questions that remain.&amp;amp;nbsp; </description>
  <author_name>ACR on Air</author_name>
  <author_url>https://www.rheumatology.org/Learning-Center/Publications-Communications/Podcast</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/43750694/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/006fba/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/item/43750694</thumbnail_url>
</oembed>
